Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JUNE 04, 2022 SAM #7491
SOLICITATION NOTICE

A -- Intent to Sole Source - RNA Sequencing � Mouse Fecal Samples

Notice Date

6/2/2022 11:13:57 AM
 

Notice Type

Combined Synopsis/Solicitation
 

NAICS

541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
 

Contracting Office

FDA OFFICE OF ACQ GRANT SVCS Beltsville MD 20705 USA
 

ZIP Code

20705
 

Solicitation Number

FDARFQ22-1254045
 

Response Due

6/9/2022 2:00:00 PM
 

Archive Date

06/24/2022
 

Point of Contact

HILDA ARYEH, James O�Keefe
 

E-Mail Address

hilda.aryeh@fda.hhs.gov, James.OKeefeIII@fda.hhs.gov
(hilda.aryeh@fda.hhs.gov, James.OKeefeIII@fda.hhs.gov)
 

Description

Description: The Government intends to negotiate and solicit with only one source, University of Michigan, for RNA Sequencing Services on four runs of mouse fecal samples under the authority of FAR 13.106(b)(1)(i). This is not a request for competitive proposals, however, any responsible offeror may submit a quote which will be given due consideration by the agency. Disclaimer: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice.� This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This acquisition is issued as a Request for Quote (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2022-04 dated 30 January 2022. For purposes of this acquisition, the associated NAICS code is 541715. The small business size standard is 1000 employees. Contract Line Item (CLIN) Structure: The following is a list of contract line item number(s) and items, quantities and units of measure, (including option(s), if applicable): Line Item 0001 - DNA-rRNA Sequencing (Fecal) Line Item 0002 (Option) - DNA-rRNA Sequencing (Fecal) Line Item 0003 (Option) - DNA-rRNA Sequencing (Fecal) Line Item 0004 (Option) - DNA-rRNA Sequencing (Fecal) Line Item 0005 (Option) - DNA-rRNA Sequencing (Fecal) Specifications/Requirement: See attached Performance Work Statement (PWS) Delivery: Period of performance is for one year from date of contract award.� Acceptance shall be performed at Destination.� The FOB point is Destination. Clauses: The provision at 52.212-1, Instructions to Offerors � Commercial DEVIATION 2018-O0018, applies to this acquisition.� The following addenda have been attached to this provision: N/A In addition to the requirements set for the in FAR 52.212-1, all offers responding to this solicitation must provide their business size in relation to the NAICS code contained in this solicitation and shall identify any socioeconomic categories to which they belong. Evaluation Criteria � N/A � See notice of intent to sole source. Offerors shall include a completed copy of the provision at FAR 52.212-3 (with its Alternate I), Offeror Representations with its offer. The clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. The following addenda have been attached to this clause � N/A The clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items applies to this acquisition.The following additional FAR clauses cited in this clause are applicable: The clause at 52.204-10, Reporting Executive Compensation and First-Tier Subcontract Awards (OCT 2018) is applicable to this acquisition. The clause at 52.209-6, Protecting the Government� Interest When Subcontracting with Contractors Debarred, Suspended, Or Proposed for Debarment (OCT 2015) is applicable to this acquisition. The clause at, 52.219-28, Post-Award Small Business Program Representation (JUL 2013) is applicable to this acquisition. The clause at, 52.222-3, Convict Labor (JUN 2003) is applicable to this acquisition. The clause at, 52.222-21, Prohibition of Segregated Facilities (APR 2015) is applicable to this acquisition. The clause at, 52.222-26, Equal Opportunity (SEP 2016) is applicable to this acquisition. The clause at, 52.222-35, Equal Opportunity for Veterans (OCT 2015) is applicable to this acquisition. The clause at, 52.222-36 ALT I, Affirmative Action for Workers with Disabilities (JUL 2014) ALT I (JUL 2014) is applicable to this acquisition. The clause at, 52.222-37, Employment Reports on Special Disabled Veterans, Veterans of The Vietnam Era, And Other Eligible Veterans (FEB 2016) is applicable to this acquisition. The clause at, 52.222-50, Combating Trafficking in Persons (JAN 2019) is applicable to this acquisition. The clause at, 52.223-18, Encouraging Contractor Policies to Ban Text Messaging While Driving (AUG 2011) is applicable to this acquisition. The clause at, 52.225-13, Restrictions on Certain Foreign Purchases (JUN 2008) is applicable to this acquisition. The clause at, 52.232-33, Payment by Electronic Funds Transfer�Central Contractor Registration (OCT 2018) is applicable to this acquisition. The following additional contract requirement(s) or terms and conditions apply (full text of all FAR/HHSAR clauses that contain fill-in information can be found in the attached Provisions and Clauses Full-Text document): The clause at 52.217-9, Option to extend the term of the contract (MAR 2000) The clause at 352.237-75 Key Personnel (Dec 15) is applicable to this acquisition. The clause at 352.239-73, Electronic and Information Technology Accessibility Notice (Dec 15) is applicable to this acquisition. The clause at 352.239-74, Electronic and Information Technology Accessibility (Dec 15) is applicable to this acquisition. This acquisition is rated under the Defense Priorities and Allocations System (DPAS) as N/A. The following notes apply to this announcement: N/A Place of Performance: White Oak FDA Building Address Building 52/72 Set Aside: N/A � See Notice of Intent to Sole Source.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/ecda05f7a18a434f9b402dd79074ede4/view)
 

Place of Performance

Address: Silver Spring, MD 20903, USA

Zip Code: 20903

Country: USA
 

Record

SN06345253-F 20220604/220602230107 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |